1-1 of 1
Kate Taylor
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Blinatumomab for Minimal Residual Disease (MRD) in Adults with B-Cell Precursor Acute Lymphoblastic Leukemia (BCP-ALL): Median Overall Survival (OS) Is Not Reached in Complete MRD Responders at a Median Follow-up of 53.1 Months

Free
Nicola Goekbuget, MD, Hervé Dombret, Gerhard Zugmaier, Massimiliano Bonifacio, Carlos Graux, Christoph Faul, MD, Max S. Topp, Monika Brüggemann, Kate Taylor, MSc, Ralf Bargou, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 554.
https://doi.org/10.1182/blood-2018-99-111516
Published: 2018